论文信息 - Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years - 字舞流文

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

M. Freedman | T. Ziemssen | K. Thangavelu | D. Baker | D. Margolin | D. Horáková | A. Bertolotto | E. Poole | A. Boster | S. Cavalier | N. Daizadeh | A. Jacobs | I. Firmino*